Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Peterson YK, Luttrell LM.

Pharmacol Rev. 2017 Jul;69(3):256-297. doi: 10.1124/pr.116.013367. Review.

PMID:
28626043
2.

srGAP1 mediates the migration inhibition effect of Slit2-Robo1 in colorectal cancer.

Feng Y, Feng L, Yu D, Zou J, Huang Z.

J Exp Clin Cancer Res. 2016 Dec 7;35(1):191.

3.

TβRIII Expression in Human Breast Cancer Stroma and the Role of Soluble TβRIII in Breast Cancer Associated Fibroblasts.

Jovanović B, Pickup MW, Chytil A, Gorska AE, Johnson KC, Moses HL, Owens P.

Cancers (Basel). 2016 Nov 4;8(11). pii: E100.

4.

Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling.

Jenkins LM, Singh P, Varadaraj A, Lee NY, Shah S, Flores HV, O'Connell K, Mythreye K.

J Biol Chem. 2016 Dec 2;291(49):25716-25728. Epub 2016 Oct 26.

PMID:
27784788
5.

Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma.

Sun WY, Hu SS, Wu JJ, Huang Q, Ma Y, Wang QT, Chen JY, Wei W.

Sci Rep. 2016 Oct 19;6:35609. doi: 10.1038/srep35609.

6.

β-Arrestin 1-dependent regulation of Rap2 is required for fMLP-stimulated chemotaxis in neutrophil-like HL-60 cells.

Gera N, Swanson KD, Jin T.

J Leukoc Biol. 2017 Jan;101(1):239-251. doi: 10.1189/jlb.2A1215-572R. Epub 2016 Aug 4.

PMID:
27493245
7.

Common pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells.

Clark CR, Robinson JY, Sanchez NS, Townsend TA, Arrieta JA, Merryman WD, Trykall DZ, Olivey HE, Hong CC, Barnett JV.

Cell Signal. 2016 Jun;28(6):688-98. doi: 10.1016/j.cellsig.2016.03.004. Epub 2016 Mar 10.

8.

Multifaceted role of β-arrestins in inflammation and disease.

Sharma D, Parameswaran N.

Genes Immun. 2015 Dec;16(8):499-513. doi: 10.1038/gene.2015.37. Epub 2015 Sep 17. Review. Erratum in: Genes Immun. 2015 Dec;16(8):576.

9.

TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.

Tazat K, Hector-Greene M, Blobe GC, Henis YI.

Mol Biol Cell. 2015 Oct 1;26(19):3535-45. doi: 10.1091/mbc.E15-04-0203. Epub 2015 Aug 12.

10.

Type III TGFβ receptor and Src direct hyaluronan-mediated invasive cell motility.

Allison P, Espiritu D, Barnett JV, Camenisch TD.

Cell Signal. 2015 Mar;27(3):453-9. doi: 10.1016/j.cellsig.2014.11.037. Epub 2014 Dec 11.

11.
12.

Characterization of type III TGF-β receptor expression in invasive breast carcinomas: a potential new marker and target for triple negative breast cancer.

Pang JC, Virani NK, Kidwell KM, Kleer CG.

J Cell Commun Signal. 2014 Sep;8(3):211-8. doi: 10.1007/s12079-014-0240-z. Epub 2014 Aug 19.

13.

The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.

Gatza CE, Elderbroom JL, Oh SY, Starr MD, Nixon AB, Blobe GC.

Neoplasia. 2014 Jun;16(6):489-500. doi: 10.1016/j.neo.2014.05.008.

14.

Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.

Elderbroom JL, Huang JJ, Gatza CE, Chen J, How T, Starr M, Nixon AB, Blobe GC.

Mol Biol Cell. 2014 Aug 15;25(16):2320-32. doi: 10.1091/mbc.E13-09-0524. Epub 2014 Jun 25.

15.

Role of TGF-β receptor III localization in polarity and breast cancer progression.

Meyer AE, Gatza CE, How T, Starr M, Nixon AB, Blobe GC.

Mol Biol Cell. 2014 Aug 1;25(15):2291-304. doi: 10.1091/mbc.E14-03-0825. Epub 2014 May 28.

16.

Cdc42 inhibits ERK-mediated collagenase-1 (MMP-1) expression in collagen-activated human keratinocytes.

Rohani MG, Pilcher BK, Chen P, Parks WC.

J Invest Dermatol. 2014 May;134(5):1230-1237. doi: 10.1038/jid.2013.499. Epub 2013 Nov 25.

17.

Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.

Knelson EH, Gaviglio AL, Tewari AK, Armstrong MB, Mythreye K, Blobe GC.

J Clin Invest. 2013 Nov;123(11):4786-98.

18.

Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.

Hanks BA, Holtzhausen A, Evans KS, Jamieson R, Gimpel P, Campbell OM, Hector-Greene M, Sun L, Tewari A, George A, Starr M, Nixon A, Augustine C, Beasley G, Tyler DS, Osada T, Morse MA, Ling L, Lyerly HK, Blobe GC.

J Clin Invest. 2013 Sep;123(9):3925-40. doi: 10.1172/JCI65745. Epub 2013 Aug 8.

19.

β-Arrestins in the immune system.

Jiang D, Xie T, Liang J, Noble PW.

Prog Mol Biol Transl Sci. 2013;118:359-93. doi: 10.1016/B978-0-12-394440-5.00014-0. Review.

20.

The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells.

Oh SY, Knelson EH, Blobe GC, Mythreye K.

Biochem J. 2013 Aug 15;454(1):79-89. doi: 10.1042/BJ20121701.

Supplemental Content

Support Center